4//SEC Filing
Galletta Christopher 4
Accession 0000950170-25-024109
CIK 0001563880other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:00 PM ET
Size
5.4 KB
Accession
0000950170-25-024109
Insider Transaction Report
Form 4
Galletta Christopher
See Remarks
Transactions
- Award
Stock Option (right to buy)
2025-02-18+41,000→ 41,000 totalExercise: $4.22Exp: 2035-02-17→ Common Stock (41,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 18, 2025. The 41,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 18, 2026 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 18, 2029.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001486099
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 4:00 PM ET
- Size
- 5.4 KB